NEO
Income statement / Annual
Last year (2023), NeoGenomics, Inc.'s total revenue was $591.64 M,
an increase of 16.07% from the previous year.
In 2023, NeoGenomics, Inc.'s net income was -$87.97 M.
See NeoGenomics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$591.64 M
|
$509.73 M
|
$484.33 M
|
$444.45 M
|
$408.83 M
|
$276.74 M
|
$258.61 M
|
$244.08 M
|
$99.80 M
|
$87.07 M
|
| Cost of Revenue |
$347.04 M |
$321.83 M |
$297.27 M |
$258.56 M |
$211.99 M |
$149.48 M |
$138.30 M |
$133.70 M |
$56.05 M |
$46.36 M |
| Gross Profit |
$244.60 M |
$187.90 M |
$187.06 M |
$185.89 M |
$196.84 M |
$127.27 M |
$120.32 M |
$110.38 M |
$43.76 M |
$40.71 M |
| Gross Profit Ratio |
0.41 |
0.37 |
0.39 |
0.42 |
0.48 |
0.46 |
0.47 |
0.45 |
0.44 |
0.47 |
| Research and Development
Expenses |
$27.31 M
|
$30.33 M
|
$21.87 M
|
$8.23 M
|
$8.49 M
|
$3.00 M
|
$3.64 M
|
$4.65 M
|
$4.20 M
|
$2.69 M
|
| General & Administrative
Expenses |
$243.10 M
|
$243.36 M
|
$221.35 M
|
$143.79 M
|
$127.99 M
|
$84.82 M
|
$88.76 M
|
$75.78 M
|
$33.63 M
|
$23.81 M
|
| Selling & Marketing
Expenses |
$70.84 M
|
$67.32 M
|
$62.59 M
|
$47.86 M
|
$47.35 M
|
$29.40 M
|
$24.54 M
|
$23.91 M
|
$11.56 M
|
$12.00 M
|
| Selling, General &
Administrative Expenses |
$313.94 M
|
$310.68 M
|
$283.94 M
|
$191.66 M
|
$175.34 M
|
$114.22 M
|
$113.30 M
|
$99.69 M
|
$45.19 M
|
$35.81 M
|
| Other Expenses |
$11.09 M |
-$213,000.00 |
-$499,000.00 |
$11.86 M |
-$4.63 M |
$14,000.00 |
-$1.32 M |
$3.46 M |
$2.00 M |
$0.00 |
| Operating Expenses |
$341.25 M |
$341.00 M |
$305.81 M |
$199.89 M |
$183.83 M |
$117.23 M |
$116.93 M |
$104.34 M |
$49.39 M |
$38.50 M |
| Cost And Expenses |
$688.29 M |
$662.84 M |
$603.08 M |
$458.44 M |
$395.82 M |
$266.70 M |
$255.23 M |
$238.05 M |
$105.44 M |
$84.85 M |
| Interest Income |
$16.90 M |
$6.08 M |
$3.14 M |
$3.06 M |
$3.71 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$6.91 M |
$1.51 M |
$5.08 M |
$7.02 M |
$3.71 M |
$6.23 M |
$5.54 M |
$10.00 M |
$854,000.00 |
$929,000.00 |
| Depreciation &
Amortization |
$72.58 M
|
$79.21 M
|
$62.07 M
|
$41.89 M
|
$35.91 M
|
$21.73 M
|
$22.59 M
|
$23.21 M
|
$7.14 M
|
$5.64 M
|
| EBITDA |
-$17.61 M
|
-$78.63 M
|
$52.08 M
|
$34.85 M
|
$43.26 M
|
$31.79 M
|
$26.55 M
|
$29.25 M
|
$3.51 M
|
$7.86 M
|
| EBITDA Ratio |
-0.03 |
-0.16 |
0.09 |
0.08 |
0.09 |
0.11 |
0.1 |
0.12 |
0.04 |
0.03 |
| Operating Income Ratio
|
-0.18
|
-0.3
|
-0.02
|
-0
|
0.02
|
0.04
|
0.01
|
0.01
|
-0.06
|
0.03
|
| Total Other
Income/Expenses Net |
$10.64 M
|
-$1.72 M
|
$103.68 M
|
-$64,000.00
|
-$9.36 M
|
-$6.22 M
|
-$5.55 M
|
-$10.00 M
|
$1.15 M
|
-$929,000.00
|
| Income Before Tax |
-$97.10 M |
-$159.34 M |
-$15.08 M |
-$14.06 M |
$3.65 M |
$3.82 M |
-$3.48 M |
-$7.42 M |
-$4.49 M |
$1.29 M |
| Income Before Tax Ratio
|
-0.16
|
-0.31
|
-0.03
|
-0.03
|
0.01
|
0.01
|
-0.01
|
-0.03
|
-0.04
|
0.01
|
| Income Tax Expense |
-$9.13 M |
-$15.09 M |
-$6.73 M |
-$18.23 M |
-$4.36 M |
$1.18 M |
-$2.64 M |
-$1.70 M |
-$1.95 M |
$157,000.00 |
| Net Income |
-$87.97 M |
-$144.25 M |
-$8.35 M |
$4.17 M |
$8.01 M |
$2.64 M |
-$846,000.00 |
-$5.72 M |
-$2.54 M |
$1.13 M |
| Net Income Ratio |
-0.15 |
-0.28 |
-0.02 |
0.01 |
0.02 |
0.01 |
-0 |
-0.02 |
-0.03 |
0.01 |
| EPS |
-0.7 |
-1.16 |
-0.0696 |
0.0384 |
0.0797 |
0.0288 |
-0.0108 |
-0.0743 |
-0.0419 |
0.02 |
| EPS Diluted |
-0.7 |
-1.16 |
-0.0696 |
0.0373 |
0.0773 |
0.0288 |
-0.0107 |
-0.0738 |
-0.0419 |
0.02 |
| Weighted Average Shares
Out |
$125.50 M
|
$124.22 M
|
$119.96 M
|
$108.58 M
|
$100.47 M
|
$91.57 M
|
$78.16 M
|
$77.04 M
|
$60.53 M
|
$53.48 M
|
| Weighted Average Shares
Out Diluted |
$125.50 M
|
$124.22 M
|
$119.96 M
|
$111.79 M
|
$103.62 M
|
$91.57 M
|
$79.43 M
|
$77.54 M
|
$60.53 M
|
$56.02 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
